30
AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update at Three Years Richard G. Ohye, M.D. Head, Section of Pediatric Cardiovascular Surgery University of Michigan C.S. Mott Children’s Hospital Congenital Heart Center

AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

Embed Size (px)

Citation preview

Page 1: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery

Lessons Learned from the SVR Trial: Update at Three Years

Richard G. Ohye, M.D.

Head, Section of Pediatric Cardiovascular Surgery

University of Michigan C.S. Mott Children’s Hospital

Congenital Heart Center

Page 2: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

Disclosure

• Sorin, Inc.– Medical Advisory Board (paid)

• Cryolife, Inc.– FDA panel testimony (unpaid)

• No off-label usage

Page 3: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

LESSONS LEARNED FROM THE SVR TRIAL: UPDATE AT THREE YEARS

AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery

Page 4: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

SVR Trial

Page 5: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

WHAT HAVE I LEARNED FROM THE SVR TRIAL?

Lessons learned from the SVR Trial: Update at Three Years

Page 6: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

I CAN DECREASE NORWOOD MORTALITY BY HALF…

From what I learned from the SVR trial…

Page 7: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

I CAN DECREASE NORWOOD MORTALITY BY HALF……TOMORROW

From what I learned from the SVR trial…

Page 8: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

What We Learned

• Norwood Procedure transplant-free survival– Median 83%– Range 93%-61%

– High Performing Centers 90%– Standard Performing Centers <80%

Page 9: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

VOLUMES-OUTCOMES RELATIONSHIPS

What else do we know?

Page 10: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

Volumes-Outcomes Relationships

Page 11: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

Volumes-Outcomes Relationships

• 2003 Kids’ Inpatient Database (KID)– Arterial Switch Operation

• n=547• 74 hospitals (range of case #, 1-24)

– Norwood Procedure • n=624• 60 hospitals (range of case #, 1-31)

Page 12: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

Volumes-Outcomes Relationships

• Inverse relationship between volume and mortality– Arterial Switch Operation (p=0.006)

• 2 ASOs/yr – 9.4% mortality• 10 ASOs/yr – 3.2% mortality• 20 ASOs/yr – 0.8% mortality

Page 13: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

Volumes-Outcomes Relationships

• Inverse relationship between volume and mortality– Norwood Procedure (p=0.001)

• 2 Norwoods/yr – 35% mortality• 10 Norwoods/yr – 26% mortality• 20 Norwoods/yr – 17% mortality

Page 14: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

Volumes-Outcomes Relationships

Page 15: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

Volumes-Outcomes Relationships

• Society of Thoracic Surgeons Congenital Heart Surgery Database (2000 to 2009)– 2,555 patients– 55 centers– 111 surgeons

Page 16: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

Volumes-Outcomes Relationships

• Lower center Norwood volume was associated with higher mortality– Odds ratio for centers with ≤10 vs. >20

cases/yr 1.56

Page 17: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

Volumes-Outcomes Relationships

• Lower surgeon Norwood volume was associated with higher mortality– Odds ratio for surgeons with ≤5 vs. >10

cases/year 1.60

Page 18: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

Volumes-Outcomes Relationships

• Adjusted mortality rates by center volume– 0-10 Norwoods/yr - 26%– 11-20 Norwoods/yr - 22%– >20 Norwoods/yr - 18%

Page 19: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

Volumes-Cost Relationship

Page 20: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

WHAT HAVE I LEARNED FROM THE SVR TRIAL?

Lessons learned from the SVR Trial: Update at Three Years

Page 21: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

PRACTICE PATTERN VARIATION

What else did we learn?

Page 22: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

What We Know

Page 23: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

SVR Trial – Practice Pattern Variation

• Pre-Operative Variation– Intubation – Range 29-91%

• Operative Variation– CPB time – Range 78-188 minutes– Lowest HCT on CPB – Range 23-40%

• Post-Operative Variation– G Tube placement – Range 2-72%– Home monitoring – Range 1-100%

• Mortality during Norwood Hospitalization– Range 7-39%

Page 24: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

Reducing Practice Pattern Variation

• Northern New England Cardiovascular Disease Study Group – The Northern New England Cardiovascular Disease

Study Group exists to develop and exchange information concerning the treatment of cardiovascular disease. It is a regional, voluntary, multi-disciplinary group of clinicians, hospital administrators, and health care research personnel who seek to improve continuously the quality, safety, effectiveness, and cost of medical interventions in cardiovascular disease.

Page 25: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

Reducing Practice Pattern Variation

• The Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative– MSTCVS Quality Collaborative Mission:

• The MSTCVS Quality Collaborative is a multidisciplinary group of medical professionals dedicated to improving the care of cardiac and general thoracic surgery patients in Michigan.

• The MSTCVS Quality Collaborative promotes and shares optimal processes of care and cardiac and general thoracic surgery outcomes and implements quality improvement initiatives based on regional and national data as well as clinical research and evidence based cardiac and thoracic surgery practice and guidelines.

Page 26: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

Reducing Practice Pattern Variation

• Pediatric Heart Network Collaborative Learning Project– Early extubation following cardiac surgery– Developed a common Clinical Practice

Guideline – Deploying CPG (5 centers)

Page 27: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

Reducing Practice Pattern Variation

• Pediatric Cardiac Critical Care Consortium (PC4)– >25 Pediatric CICU– Common nomenclature– Collecting data– Real-time performance data– Developing best practices

Page 28: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

WHAT HAVE I LEARNED FROM THE SVR TRIAL?

Lessons learned from the SVR Trial: Update at Three Years

Page 29: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

IT AIN’T ABOUT THE SHUNTLessons learned from the SVR Trial: Update at Three Years

Page 30: AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update

AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery

Lessons Learned from the SVR Trial: Update at Three Years

Richard G. Ohye, M.D.

Head, Section of Pediatric Cardiovascular Surgery

University of Michigan C.S. Mott Children’s Hospital

Congenital Heart Center